Delivery Order SPE2DB24D1021-SPE2DB25FEXGF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $14,596.00. The contract represents a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes valued at $7,691.00 with a firm fixed price structure. This non-competitive delivery order, issued on November 12, 2025, is scheduled for completion by December 4, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.60 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL) on August 29, 2025, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, non-set-aside delivery order issued without competitive restrictions, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.00 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 ml syringes on October 20, 2025. This is a firm fixed price, non-set-aside contract with performance expected to be completed by November 10, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal healthcare systems. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on August 5, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single pharmaceutical supply transaction within the company's broader federal contract portfolio. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,459.25 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 1, 2025, with completion scheduled for December 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $36,490 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gel-One 30 mg/3 mL syringes under a firm fixed-price contract. The order is expected to be completed by October 17, 2025, with performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. This is a non-set-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal medical supply...
- The Defense Logistics Agency awarded a $3,845.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 12, 2025, with an ultimate completion date of January 6, 2026. The non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's comprehensive pharmaceutical supply agreement with the DLA. This award falls...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXGFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes valued at $6,568.20 on June 2, 2025, with completion scheduled for June 24, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical medical supplies to support federal healthcare needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains. The DLA Troop Support is pursuing a strategic approach to pharmaceutical procurement through multiple regional contracts under the Pharmaceutical Prime Vendor Global Program Generation V initiative, positioning AmerisourceBergen as a key vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 6/2/25 |